• Home
  • Agric
  • Sci & Tech
  • Health
  • Environment
  • Hausa News
  • More
    • Business/Banking & Finance
    • POLITICS
    • Entertainments & Sports
    • International
    • Investigation
    • Law & Human Rights
    • Africa
    • ACCOUNTABILITY/CORRUPTION
    • Hassan Gimba
    • Column
    • Prof. Jibrin Ibrahim
    • Prof. M.K. Othman
    • Defense/Security
    • Education
    • Energy/Electricity
    • Entertainment/Arts & Sports
    • Society and Lifestyle
    • Food & Agriculture
    • Health & Healthy Living
    • International News
    • Interviews
    • Investigation/Fact-Check
    • LAW & HUMAN RIGHTS
    • Oil & Gas/Mineral Resources
    • PRESS FREEDOM/JOURNALISM/PR
    • General News
    • Presidency
  • About Us
    • Contact Us
    • Board Of Advisory
    • Privacy Policy
    • Ethics Policy
    • Teamwork And Collaboration Policy
    • Fact-Checking Policy
    • Advertising
  • Media OutReach Newswire
    • Wire News
  • The Stories
Facebook Twitter Instagram
Trending
  • Smallholders unable to afford essential farm inputs, expert says
  • Farmers say high costs drive up catfish prices
  • NEWSAN calls for urgent repairs to sewage systems
  • Rising feed costs push farmers out of business
  • Naira slips to ₦1,379.99/$ as interbank FX turnover tops $500m
  • FAAC shares ₦2.44trn October revenue as statutory, VAT receipts decline
  • State trains veterinarians to expand rural services
  • UniCal Alumni turn to agribusiness to tackle graduate unemployment
Facebook Twitter Instagram YouTube
AsheNewsAsheNews
  • Home
  • Agric

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    Rising feed costs push farmers out of business

    November 19, 2026

    State trains veterinarians to expand rural services

    November 19, 2026

    UniCal Alumni turn to agribusiness to tackle graduate unemployment

    November 19, 2026
  • Sci & Tech

    Sultan inaugurates 500-seat ICT centre at Saki nursing college, backs health technology expansion

    November 19, 2026

    Linking payment systems key to Africa’s trade integration, officials say

    November 19, 2026

    CJID announces 2026 media, development conference

    November 18, 2026

    GOVMAIL adoption grows across Nigeria’s public sector

    November 17, 2026

    CADEF: Low public trust threatens Nigeria’s energy transition

    November 14, 2026
  • Health

    Foundation, ACF urge investment in boys’ development

    November 19, 2026

    Nigeria’s home care framework launched to support vulnerable people

    November 19, 2026

    WHO calls for coordinated action to curb antimicrobial resistance

    November 19, 2026

    Men should seek early medical care, NMA chief says

    November 19, 2026

    First lady calls for UN recognition of men’s day

    November 19, 2026
  • Environment

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026

    Nigeria targets open defecation free status by 2030

    November 19, 2026

    Erosion puts Cross River transmission line at risk

    November 19, 2026

    Partnership targets open defecation in 8 states

    November 18, 2026

    Air Peace adds more daily flights between Lagos, Abuja

    November 18, 2026
  • Hausa News

    Foundation unveils public sector reform playbook

    November 12, 2026

    Tinubu asks Reps to approve N10.79tn external borrowing for 2026 budget

    November 11, 2026

    UNA signs MoU to launch air Bissau in Guinea-Bissau

    June 15, 2026

    Otti plans 250-room 5-star hotel in Umuahia

    April 11, 2026

    Anti-quackery task force seals 4 fake hospitals in Rivers

    August 29, 2025
  • More
    1. Business/Banking & Finance
    2. POLITICS
    3. Entertainments & Sports
    4. International
    5. Investigation
    6. Law & Human Rights
    7. Africa
    8. ACCOUNTABILITY/CORRUPTION
    9. Hassan Gimba
    10. Column
    11. Prof. Jibrin Ibrahim
    12. Prof. M.K. Othman
    13. Defense/Security
    14. Education
    15. Energy/Electricity
    16. Entertainment/Arts & Sports
    17. Society and Lifestyle
    18. Food & Agriculture
    19. Health & Healthy Living
    20. International News
    21. Interviews
    22. Investigation/Fact-Check
    23. LAW & HUMAN RIGHTS
    24. Oil & Gas/Mineral Resources
    25. PRESS FREEDOM/JOURNALISM/PR
    26. General News
    27. Presidency
    Featured
    Recent

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026
  • About Us
    1. Contact Us
    2. Board Of Advisory
    3. Privacy Policy
    4. Ethics Policy
    5. Teamwork And Collaboration Policy
    6. Fact-Checking Policy
    7. Advertising
    Featured
    Recent

    Smallholders unable to afford essential farm inputs, expert says

    November 19, 2026

    Farmers say high costs drive up catfish prices

    November 19, 2026

    NEWSAN calls for urgent repairs to sewage systems

    November 19, 2026
  • Media OutReach Newswire
    • Wire News
  • The Stories
AsheNewsAsheNews
Home»Health & Healthy Living»Twice-yearly HIV injection approved by FDA, but price raises alarm
Health & Healthy Living

Twice-yearly HIV injection approved by FDA, but price raises alarm

NewsdeskBy NewsdeskJune 23, 2025Updated:June 23, 2025No Comments4 Mins Read
HIV AIDS test kits, anti-retroviral drugs1
Illustrative image of HIV AIDS test kits, anti-retroviral drugs
Share
Facebook Twitter LinkedIn Pinterest Email

Reactions have continued to trail the approval of Yeztugo, a twice-yearly injectable medication for HIV prevention, with experts warning that its high cost could shut out millions of vulnerable people worldwide.

The concerns were raised by experts in an interview with the News Agency of Nigeria (NAN) on Sunday in Abuja.

NAN reports that the United States Food and Drug Administration (FDA) recently approved long-acting injectable Lenacapavir for HIV prevention.

The medicine, to be administered once every six months, represents a significant advancement in expanding prevention options for people at risk of HIV infection across the globe.

In two major clinical trials concluded in 2024, Gilead’s injection, marketed as Yeztugo proved highly effective in virtually eliminating new HIV infections when taken twice a year.

Its low-dose frequency makes it more convenient than existing prevention options, including daily oral PrEP pillslike Truvada and Descovy, and GSK’s Apretude, taken every other month.

According to Gilead CEO, Daniel O’Day, this really will bend the arc of the epidemic as we roll this out globally,

”However, Gilead’s announcement of a U.S. list price of 28,218 dollars per person per year has drawn global criticism.

Health leaders and HIV advocates warn that the pricing risks making the life-saving medication inaccessible to those most in need.

A research paper published in the Lancet HIV this week estimated that generic Lenacapavir could be produced for as little as 35dollars to 46 dollars per person per year.

The research said that it had the potential of dropping to 25 dollars with committed demand, making it comparable to existing oral PrEP.

Winnie Byanyima, Executive Director of UNAIDS and United Nations Under-Secretary-General, welcomed the FDA approval but demanded urgent action on pricing and access.

According to her, Lenacapavir could be the tool we need to bring new infections under control, but only if it is priced affordably and made available to everyone who could benefit.

“This is a breakthrough moment. The approval of Lenacapavir is a testament to decades of public investment, scientific excellence, and the contributions of trial participants and communities.

“It is beyond comprehension how Gilead can justify a price of 28,218 dollars. If this game-changing medicine remains unaffordable, it will change nothing,” she said.

Prof. Oyewale Tomori, a renowned virologist and former President of the Nigerian Academy of Science, also commended the scientific milestone but said that the situation reflected a deeper problem for the African continent.

“Until African countries begin to produce and manufacture their vaccines and treatments, such disparities in access are to be expected.

“We must invest significantly in local research, biotechnology, and pharmaceutical development.

“Only through self-reliance can the continent avoid being perpetually left behind during major health breakthroughs,” Tomori said.

Mr Jeremiah Johnson, Executive Director of PrEP4All, highlighted the urgent need to bridge the access gap.

“It’s not enough to have the science, we need it in the hands of those who need it most,” he said.

NAN recalls that Gilead has pledged to provide copay savings to reduce out-of-pocket costs to zero for eligible insured patients and to offer free access to qualifying uninsured individuals in the U.S.

The company also expects broad insurance coverage, similar to existing HIV prevention therapies.

Lenacapavir is already approved for treating HIV under the brand name Sunlenca, which has a U.S. price list exceeding 42,200 per year.

To support global access, Gilead has licensed six generic manufacturers to produce and sell low-cost versions of the injection in 120 low- and lower-middle-income countries.

The company also pledged to supply doses for up to two million people at no profit before generic versions reach the market.

Gilead said that HIV knows no boundaries, reinforcing its commitment to equitable access.

Meanwhile, daily PrEP pills have been available for over a decade.

However, their effectiveness has been limited in many communities due to stigma, inconvenience, and adherence challenges.

As Gilead prepares to roll out Yeztugo globally, public health advocates seek bold steps to ensure that the innovation becomes a symbol of inclusion and equity, not exclusion and disparity.

anti-venom injection FDA Medication
Share. Facebook Twitter Pinterest LinkedIn WhatsApp Reddit Tumblr Email
Newsdesk
  • Website

Related Posts

Foundation, ACF urge investment in boys’ development

November 19, 2026

Nigeria’s home care framework launched to support vulnerable people

November 19, 2026

WHO calls for coordinated action to curb antimicrobial resistance

November 19, 2026

Leave A Reply Cancel Reply

Smallholders unable to afford essential farm inputs, expert says

November 19, 2026

Farmers say high costs drive up catfish prices

November 19, 2026

NEWSAN calls for urgent repairs to sewage systems

November 19, 2026

Rising feed costs push farmers out of business

November 19, 2026
About Us
About Us

ASHENEWS (AsheNewsDaily.com), published by PenPlus Online Media Publishers, is an independent online newspaper. We report development news, especially on Agriculture, Science, Health and Environment as they affect the under-reported rural and urban poor.

We also conduct investigations, especially in the areas of ASHE, as well as other general interests, including corruption, human rights, illicit financial flows, and politics.

Contact Info:
  • 1st floor, Dogon Daji House, No. 5, Maiduguri Road, Sokoto
  • +234(0)7031140009
  • ashenewsdaily@gmail.com
Facebook Twitter Instagram Pinterest
© 2026 All Rights Reserved. ASHENEWS Daily Designed & Managed By DeedsTech

Type above and press Enter to search. Press Esc to cancel.